Scientist participates in IPVC 2023
Dr Nivashnee Naicker, CAPRISA Research Clinician and HVTN/COVPN site PI at the CAPRISA eThekwini Clinical Research Site attended and participated in the 35th International Papillomavirus Conference, IPVC 2023, held in Washington DC from 17-21 April 23.
Naicker was invited to speak at the Cepheid symposium on the real-world implementation of Xpert® HPV in high risk populations. Her presentation on ‘A novel cervical cancer screening approach using GeneXpert technology for WLHIV, South Africa’, preliminary data from the STREAM HIV trial, was well received.